AAOpt 2023: A look into eSight's wearable technologies

News
Video

Learn what's in the pipeline for eSight, as well as hear how their current technology helps patients.

Roland Mattern and Gary Foster caught up with Optometry Times during the 2023 American Academy of Optometry meeting in New Orleans to share what's new with eSight.

Video transcript

Editor's note: This transcript has been lightly edited for clarity.

Roland Mattern:
Hi there, I'm Roland Mattern, Director of Sales Marketing for eSight.

Gary Foster:
I'm Gary Foster. I've been wearing eSight since 2015.

Mattern:
We're at AAO in New Orleans 2023, showcasing our wearable technologies simply designed for central vision loss and low vision patients. We are showcasing our eSight 4 product which is currently in the market. We're also getting a sneak peek to our visitors to eSight Go, which is our newest technology to launch next year. The eSight Go features a wider field of view and a slider. [It's] certainly more subtle in design, has better resolution monitors, better brightness, [and] easy navigate software. It's really a step up in all facets over current products. Gary, you've been wearing eSight, you mentioned, [since] 2015? What's your perspective been on what it's done for you?

Foster:
Well, in my case, my acuity is 20/400. I'm legally blind, I have no central vision at all. But, when I wear eSight, I can read to the bottom of the eye chart, which absolutely blows my mind. Anybody that's familiar with macular degeneration will understand, but I say I can thread a needle with ease. That sounds like something that should be impossible. It actually gives me full central vision when I wear the eSight eyewear. I wear it in such a way that I can navigate looking underneath the eyewear with my peripheral vision. So, I'm always oriented wherever I am. When I need fine detail, I just look through the glasses and then I can see that, like a sign halfway down the room. I treat it like reverse bifocals. So, it's life changing. It gave me my independence back and they actually put me back to work.

Mattern:
Are there any hobbies that you couldn't do without eSight?

Foster:
[I] pretty much couldn't do any hobbies. But now I do everything I ever did before, except drive a car. I mean, I'm a woodworker. But more than that, I start in the forest, I drop the tree. I can't take the tree to the mill, I have my own mill. I mill the wood and then they take the wood to my shop and then I build my projects. I could not do any of that if I didn't have eSight.

Mattern:
It's unbelievable. So our technology, the camera, and the monitors in our new eSight Go glasses really has [an] incredible impact on our wearers. [It] gives independence back, brings back their loved ones into their life as you recognize faces, or play cards, pursue hobbies, all the things that vision loss is taking away from them. So, come see us at eSight 2023 or online at esighteyewear.com and check out our latest tech.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Steven Greenstein, MD, one of the cochairs of the Collaborative Care Symposium gave some insight into the upcoming conference and what attendees can expect.
Dr Julie Poteet reports on patient-reported outcomes using lipid-containing artificial tear
Karl Stonecipher ASCRS 2025
© 2025 MJH Life Sciences

All rights reserved.